A Phase I/II Study of First Line Gemcitabine, Cisplatin and MEK162 in Advanced Biliary Tract Carcinoma
Phase of Trial: Phase I/II
Latest Information Update: 07 Jun 2019
At a glance
- Drugs Binimetinib (Primary) ; Cisplatin; Gemcitabine
- Indications Biliary cancer; Carcinoma; Cholangiocarcinoma; Gallbladder cancer; Liver cancer
- Focus Adverse reactions; Therapeutic Use
- 03 Jun 2019 Status changed from active, no longer recruiting to completed.
- 01 May 2019 Planned End Date changed from 1 Apr 2019 to 1 Apr 2020.
- 01 May 2019 Planned primary completion date changed from 1 Apr 2019 to 1 Apr 2020.